Tenascin-C and fibronectin expression divide early stage tongue cancer into low-and high-risk groups

British Journal of Cancer

Volumn 116, Issue 5, 2017, Pages 640-648

  Sundquist, Elias ^a,b   Kauppila, Joonas H ^a,b,c   Veijola, Johanna ^a   Mroueh, Rayan ^d   Lehenkari, Petri ^a,b   Laitinen, Saara ^e   Risteli, Juha ^a,b,f   Soini, Ylermi ^g,h   Kosma, Veli Matti ^g,h   Sawazaki Calone, Iris ⁱ   MacEdo, Carolina Carneiro Soares ^j   Bloigu, Risto ^a   Coletta, Ricardo D ^j   Salo, Tuula ^a,b,d  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF HELSINKI   (Finland)

^e FINNISH RED CROSS BLOOD SERVICE   (Finland)

^f Laboratory of Cancer Genetics and Tumor Biology   (Finland)

^g UNIVERSITY OF EASTERN FINLAND   (Finland)

^h KUOPIO UNIVERSITY HOSPITAL   (Finland)

ⁱ UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

^j UNIVERSITY OF CAMPINAS   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FIBRONECTIN; TENASCIN;

ADJUVANT RADIOTHERAPY; ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; EARLY CANCER; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LOW RISK POPULATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MESENCHYMAL STROMA CELL; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SURVIVAL RATE; TONGUE CARCINOMA; CANCER STAGING; DISEASE MANAGEMENT; METABOLISM; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; STROMA CELL; SURVIVAL ANALYSIS; TONGUE TUMOR;

CARCINOMA, SQUAMOUS CELL; DISEASE MANAGEMENT; FEMALE; FIBRONECTINS; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; STROMAL CELLS; SURVIVAL ANALYSIS; TENASCIN; TONGUE NEOPLASMS;

EID: 85009747676     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2016.455     Document Type: Article

References (50)

1. Al Moustafa A-E, Alaoui-Jamali MA, Batist G, Hernandez-Perez M, Serruya C, Alpert L, Black MJ, Sladek R, Foulkes WD (2002) Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 21(17): 2634-2640.
2. Almangush A, Bello IO, Keski-Säntti H, Mäkinen LK, Kauppila JH, Pukkila M, Hagström J, Laranne J, Tommola S, Nieminen O, Soini Y, Kosma V-M, Koivunen P, Grénman R, Leivo I, Salo T (2014) Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck 36(6): 811-818.
3. Bagordakis E, Sawazaki-Calone I, Macedo CC, Carnielli CM, de Oliveira CE, Rodrigues PC, Rangel AL, Dos Santos JN, Risteli J, Graner E, Salo T, Leme AF, Coletta RD (2016) Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures. Tumour Biol 37(7): 9045-9057.
4. Barnes L, Eveson JW, Reichart P, Sidransky D (2005) Pathology and Genetics of Head and Neck Tumours. IARC Press: Lyon.
5. Bello IO, Soini Y, Salo T (2010) Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I). Oral Oncol 46(9): 630-635.
6. Bello IO, Vered M, Dayan D, Dobriyan A, Yahalom R, Alanen K, Nieminen P, Kantola S, Läärä E, Salo T (2011) Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer. Oral Oncol 47(1): 33-38.
7. Brunner A, Mayerl C, Tzankov A, Yerdorfer I, Tschörner I, Rogatsch H, Mikuz G (2004) Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer. J Clin Pathol 57(9): 927-931.
8. Chong HC, Tan CK, Huang R-L, Tan NS (2012) Matricellular proteins: a sticky affair with cancers. J Oncol 2012: 351089.
9. D'Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, Agarwal JP, Pantvaidya G, Chaukar D, Deshmukh A, Kane S, Arya S, Ghosh-Laskar S, Chaturvedi P, Pai P, Nair S, Nair D, Badwe R (2015) Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 373(6): 521-529.
10. de Vlieghere E, Verset L, Demetter P, Bracke M, de Wever O (2015) Cancer-associated fibroblasts as target and tool in cancer therapeutics and diagnostics. Virchows Arch 467(4): 367-382.
11. Driemel O, Dahse R, Berndt A, Pistner H, Hakim SG, Zardi L, Reichert TE, Kosmehl H (2007) High-molecular tenascin-C as an indicator of atypical cells in oral brush biopsies. Clin Oral Invest 11(1): 93-99.
12. Emoto K, Yamada Y, Sawada H, Fujimoto H, Ueno M, Takayama T, Kamada K, Naito A, Hirao S, Nakajima Y (2001) Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma. Cancer 92(6): 1419-1426.
13. Ferrari D, Codecà C, Fiore J, Moneghini L, Bosari S, Foa P (2009) Biomolecular markers in cancer of the tongue. J Oncol 2009: 412908.
14. Ganly I, Patel S, Shah J (2012) Early-stage squamous cell cancer of the oral tongue-clinicopathologic features affecting outcome. Cancer 118(1): 101-111.
15. Grunow R, D'Apuzzo M, Wyss-Coray T, Frutig K, Pichler WJ (1994) A cell surface ELISA for the screening of monoclonal antibodies to antigens on viable cells in suspension. J Immunol Methods 171(1): 93-102.
16. Hanamura N, Yoshida T, Matsumoto E-I, Kawarada Y, Sakakura T (1997) Expression of fibronectin and tenascin-C mRNA by myofibroblasts, vascular cells and epithelial cells in human colon adenomas and carcinomas. Int J Cancer 73(1): 10-15.
17. Herold-Mende C, Mueller MM, Bonsanto MM, Schmitt HP, Kunze S, Steiner H-H (2002) Clinical impact and functional aspects of tenascin-C expression during glioma progression. Int J Cancer 98(3): 362-369.
18. Hindermann W, Berndt A, Borsi L, Luo X, Hyckel P, Katenkamp D, Kosmehl H (1999) Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma. J Pathol 189(4): 475-480.
19. Ioachim E, Charchanti A, Briasoulis E, Karavasilis V, Tsanou H, Arvanitis DL, Agnantis NJ, Pavlidis N (2002) Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur J Cancer 38(18): 2362-2370.
20. Ioachim E, Michael M, Stavropoulos NE, Kitsiou E, Salmas M, Malamou-Mitsi V (2005) A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma. BJU Int 95(4): 655-659.
21. Ishihara A, Yoshida T, Tamaki H, Sakakura T (1995) Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin Cancer Res 1(9): 1035-1041.
22. Jahkola T, Toivonen T, Virtanen I, Von Smitten K, Nordling S, Von Boguslawski K, Haglund C, Nevanlinna H, Blomqvist C (1998) Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence. Br J Cancer 78(11): 1507-1513.
23. Jahkola T, Toivonen T, Von Smitten K, Virtanen I, Wasenius V-M, Blomqvist C (1999) Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin C and other factors. Br J Cancer 80(1-2): 167-174.
24. Kääriäinen E, Nummela P, Soikkeli J, Yin M, Lukk M, Jahkola T, Virolainen S, Ora A, Ukkonen E, Saksela O, Hölttä E (2006) Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen-I forming specific channel structures for invasion. J Pathol 210(2): 181-191.
25. Kaarteenaho-Wiik R, Soini Y, Pöllänen R, Pääkkö P, Kinnula VL (2003) Over-expression of tenascin-C in malignant pleural mesothelioma. Histopathology 42(3): 280-291.
26. Kellermann MG, Sobral LM, da Silva SD, Zecchin KG, Graner E, Lopes MA, Nishimoto I, Kowalski LP, Coletta RD (2007) Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology 51(6): 849-853.
27. Kelner N, Rodrigues PC, Bufalino A, Fonseca FP, Santos-Silva AR, Miguel MC, Pinto CA, Leme AF, Graner E, Salo T, Kowalski LP, Coletta RD (2015) Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma. Head Neck 37(4): 479-486.
28. Kim K-Y, Cha I-H (2012) The identification of significant chromosomal regions correlated with oral tongue cancer progression. J Cancer Res Clin Oncol 138(10): 1667-1677.
29. Koljonen V, Jahkola T, Tukiainen E, Granroth G, Haglund C, Böhling T (2005) Tenascin-C in primary Merkel cell carcinoma. J Clin Pathol 58(3): 297-300.
30. Leins A, Riva P, Lindstedt R, Davidoff MS, Mehraein P, Weis S (2003) Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Cancer 98(11): 2430-2439.
31. Leskelä H-V, Risteli J, Niskanen S, Koivunen J, Ivaska KK, Lehenkari P (2003) Osteoblast recruitment from stem cells does not decrease by age at late adulthood. Biochem Biophys Res Commun 311(4): 1008-1013.
32. Li H, Zhang J, Chen S-W, Liu LL, Li L, Gao F, Zhuang S-M, Wang L-P, Li Y, Song M (2015) Cancer-associated fibroblasts provide a suitable microenvironment for tumor development and progression in oral tongue squamous cancer. J Transl Med 13(1): 198.
33. Lyons AJ, Bateman AC, Spedding A, Primrose JN, Mandel U (2001) Oncofetal fibronectin and oral squamous cell carcinoma. Br J Oral Maxillofac Surg 39(6): 471-477.
34. Mackie EJ, Halfter W, Liverani D (1988) Induction of tenascin in healing wounds. J Cell Biol. 107(6): 2757-2767.
35. Mao Y, Schwarzbauer JE (2005) Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol 24(6): 389-399.
36. Metwaly H, Maruyama S, Yamazaki M, Tsuneki M, Abé T, Jen KY, Cheng J, Saku T (2012) Parenchymal-stromal switching for extracellular matrix production on invasion of oral squamous cell carcinoma. Hum Pathol 43(11): 1973-1981.
37. Midwood KS, Orend G (2009) The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 3(3-4): 287-310.
38. Orend G, Chiquet-Ehrismann R (2006) Tenascin-C induced signaling in cancer. Cancer Lett 244(2): 143-163.
39. O'Shannessy DJ, Somers EB, Chandrasekaran LK, Nicolaides NC, Bordeaux JB, Gustavson MD (2014) Influence of tumor micro-environment on prognosis in colorectal cancer: tissue architecture-dependent signature of endosialin (TEM-1) and associated proteins. Oncotarget 5(12): 3983-3995.
40. Ramos DM, Chen B, Regezi J, Zardi L, Pytela R (1998) Tenascin-C matrix assembly in oral squamous cell carcinoma. Int J Cancer 75(5): 680-687.
41. Rybak J, Roesli C, Kaspar M, Villa A, Neri D (2007) The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res 67(22): 10948-10957.
42. Salo S, Bitu C, Merkku K, Nyberg P, Bello IO, Vuoristo J, Sutinen M, Vähänikkilä H, Costea DE, Kauppila J, Lehenkari P, Dayan D, Vered M, Risteli J, Salo T (2013) Human bone marrow mesenchymal stem cells induce collagen production and tongue cancer invasion. PLoS One 8(10): e77692.
43. Sis B, Sagol O, Küpelioglu A, Sokmen S, Terzi C, Fuzun M, Özer E, Bishop P (2004) Prognostic significance of matrix metalloproteinase-2, cathepsin D, and tenascin-C expression in colorectal carcinoma. Pathol Res Pract 200(5): 379-387.
44. Sobral LM, Bufalino A, Lopes MA, Graner E, Salo T, Coletta RD (2011) Myofibroblasts in the stroma of oral cancer promote tumorigenesis via secretion of activin A. Oral Oncol 47(9): 840-846.
45. Stivarou T, Patsavoudi E (2015) Extracellular molecules involved in cancer cell invasion. Cancers 7(1): 238-265.
46. Tiitta O, Happonen RP, Virtanen I, Luomanen M (1994) Distribution of tenascin in oral premalignant lesions and squamous cell carcinoma. J Oral Pathol Med 23(10): 446-450.
47. Varga I, Hutóczki G, Szemcsák CD, Zahuczky G, Tóth J, Adamecz Z, Kenyeres A, Bognár L, Hanzély Z, Klekner A (2012) Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma. Pathol Oncol Res 18(2): 413-420.
48. White ES, Baralle FE, Muro AF (2008) New insights into form and function of fibronectin splice variants. J Pathol 216(1): 1-14.
49. Yang Z-T, Yeo S-Y, Yin Y-X, Lin Z-H, Lee H-M, Xuan Y-H, Cui Y, Kim S-H (2016) Tenascin-C, a prognostic determinant of esophageal squamous cell carcinoma. PLoS One 11(1): e0145807.
50. Yoshida T, Matsumoto E-I, Hanamura N, Kalembyi I, Katsuta K, Ishihara A, Sakakura T (1997) Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast. J Pathol 182(4): 421-428.